Connect with us

Bloomberg Technology

Sorrento’s Covid-19 Antibody in Question

May.22 — Sorrento Therapeutics recently said its antibody cocktail has shown 100% inhibition of Covid-19 virus infection, but critics have begun to question its efficacy. Dr. Henry Ji, chairman and chief executive officer at Sorrento Therapeutics, discusses on “Bloomberg Technology.”

Published

on

May.22 — Sorrento Therapeutics recently said its antibody cocktail has shown 100% inhibition of Covid-19 virus infection, but critics have begun to question its efficacy. Dr. Henry Ji, chairman and chief executive officer at Sorrento Therapeutics, discusses on “Bloomberg Technology.”

Continue Reading
Advertisement
25 Comments

25 Comments

  1. Xu Caesar

    May 22, 2020 at 11:51 pm

    CCP Spy!Pay attention!!They want to stole vaccine!!

    • Shaun

      May 23, 2020 at 12:13 am

      Xu Caesar With the whole f—king world trying to come up with a vaccine together, why would the US be hiding their own? For monopoly?

    • Eco Builder

      May 23, 2020 at 7:41 am

      Too late China announced the CURE last night … same thing as DR Henry of SRNE. China tested on humans while FDA is sleeping and not approving Dr henry to move ahead

  2. Fire

    May 23, 2020 at 1:49 am

    pump and dump DONT BUY !!!!

    • DoubleHarmony

      May 23, 2020 at 3:07 am

      Short and Distort don’t fall for it

    • Eco Builder

      May 23, 2020 at 7:39 am

      BUY BUY BUY … China just made the announcement cure found tested on humans. exactly the same thing

  3. Fire

    May 23, 2020 at 1:49 am

    HENRY JI IS A FAILURE !!!!!!

    • DoubleHarmony

      May 23, 2020 at 3:05 am

      Short and Distort attempt, don’t listen to these fools.

    • Eco Builder

      May 23, 2020 at 7:40 am

      AMERICA is first to discover and announce a cure. We are proud of Dr Henry

    • Fire

      May 23, 2020 at 8:49 am

      @Eco Builder he said he doesnt have cure he has antibody LMFAO. he lied !!!!

  4. BasundhiBiryani

    May 23, 2020 at 2:09 am

    It’s just a concept/theory they have, no cure found. Manipulated stock, should be delisted

    • Eco Builder

      May 23, 2020 at 7:37 am

      Listen careful. If you are just infected, you can be cured within 4 days. It can also use as preventive antidode
      But not like vaccine to cure those already suffering from infection long period

  5. Joe Bloe

    May 23, 2020 at 5:42 am

    Good — no Emily Chang!! Taylor is a much better host!

  6. Sadak Vali Syed Vajrakarur

    May 23, 2020 at 6:35 am

    It is pump and dump company I have lost $400 should sue this company announcing COVID19 fake antibody news into market

    • Eco Builder

      May 23, 2020 at 7:35 am

      if you lose money go screw Hindenburg … they short sell to make millions in profit on day one. Cure is real

    • Sadak Vali Syed Vajrakarur

      May 23, 2020 at 7:41 am

      @Eco Builder Not sure who are they ultimately I have lost money which I have hard earned money scooped up by this kind of news so pathetic

  7. M. D

    May 23, 2020 at 7:02 am

    People should not blame poor trading on a company lol I also bought hi but sold and bought lower minimize your risk

  8. Davian's Dad

    May 23, 2020 at 8:17 am

    Back to $10 tomorrow. 🙂

    • ahmet durmaz

      May 23, 2020 at 10:43 am

      Why that

    • Davian's Dad

      May 25, 2020 at 6:48 pm

      ahmet durmaz you didn’t see it go to $10.

  9. Art Of Money

    May 23, 2020 at 3:51 pm

    People need to understand when you invest in Biotech companies make sure you know exactly if they are in Phase 1, Phase 2 or 3. Phase 1 news is only a reaction play for a quick trade. The final product could take months and is for long holders. Pick your time frame and trade it accordingly!

    • thu vu

      May 24, 2020 at 5:32 pm

      When is the good time to invest in?

    • ahmet durmaz

      May 24, 2020 at 6:56 pm

      @thu vu buy now or regret it later

  10. Ajaypal Singh

    May 24, 2020 at 3:53 pm

    People blaming company .. thts funny 😄 people tell me how much money you loose when you stocks no matter what you buy. Once a blue moon you make money

  11. Shadow Gallery

    May 25, 2020 at 10:24 pm

    Watch closely. Those who are polarizing….good faith…..pulled out of Novavax for this company….

Leave a Reply

Your email address will not be published. Required fields are marked *

Bloomberg Technology

Tech Leaders Approach Trump, Intel Seeks Altera Buyers | Bloomberg Technology

Bloomberg’s Caroline Hyde breaks down how President-elect Donald Trump and Elon Musk wield their political power as the government works to avoid shutting down. Plus, the Big Tech leader merry-go-round at Mar-a-Lago continues with Jeff Bezos the latest to try and influence Trump’s policies and decisions. And, private equity firms are competing for Intel’s programmable…

Published

on

Bloomberg’s Caroline Hyde breaks down how President-elect Donald Trump and Elon Musk wield their political power as the government works to avoid shutting down. Plus, the Big Tech leader merry-go-round at Mar-a-Lago continues with Jeff Bezos the latest to try and influence Trump’s policies and decisions. And, private equity firms are competing for Intel’s programmable chip arm Altera.
——–
“Bloomberg Technology” is our daily news program focused exclusively on technology, innovation and the future of business hosted by Ed Ludlow from San Francisco and Caroline Hyde in New York.

Like this video? Subscribe and turn on the notifications for Bloomberg Technology on YouTube:

Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:

Get the latest in tech from Silicon Valley and around the world here:

Follow Ed Ludlow on Twitter here:
Follow Caroline Hyde on Twitter here:

Connect with us on…
Twitter:
Facebook:
Instagram:

Continue Reading

Bloomberg Technology

The Rise of Agentic AI

Creatio CEO and Founder Katherine Kostereva joins Caroline Hyde to discuss the rise of AI agents taking front-line interactions from customer service to sales, and to give her outlook for the space in 2025. She speaks on “Bloomberg Technology.” ——– Like this video? Subscribe to Bloomberg Technology on YouTube:   Watch the latest full episodes…

Published

on

Creatio CEO and Founder Katherine Kostereva joins Caroline Hyde to discuss the rise of AI agents taking front-line interactions from customer service to sales, and to give her outlook for the space in 2025. She speaks on “Bloomberg Technology.”
——–
Like this video? Subscribe to Bloomberg Technology on YouTube:

 
Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:

 
Get the latest in tech from Silicon Valley and around the world here:

Connect with us on…
X:
Facebook:
Instagram:
 
Follow Ed Ludlow on X here:
Follow Caroline Hyde on X here:
 
Listen to the daily Bloomberg Technology podcast here:

 
More from Bloomberg Business
Connect with us on…
X:
Facebook:
Instagram:
LinkedIn:
TikTok:

Continue Reading

Bloomberg Technology

Bitcoin Slumps: Trump Euphoria Gives Way to Fed Wariness

Bitwise Asset Management CIO Matt Hougan tells Caroline Hyde why he believes the latest weakness in crypto and Bitcoin over the last few days is a “healthy pullback” which does not take away from the asset class’s overall great run this year. He speaks on “Bloomberg Technology.” ——– Like this video? Subscribe to Bloomberg Technology on…

Published

on

Bitwise Asset Management CIO Matt Hougan tells Caroline Hyde why he believes the latest weakness in crypto and Bitcoin over the last few days is a “healthy pullback” which does not take away from the asset class’s overall great run this year. He speaks on “Bloomberg Technology.”
——–
Like this video? Subscribe to Bloomberg Technology on YouTube:

 
Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:

 
Get the latest in tech from Silicon Valley and around the world here:

Connect with us on…
X:
Facebook:
Instagram:
 
Follow Ed Ludlow on X here:
Follow Caroline Hyde on X here:
 
Listen to the daily Bloomberg Technology podcast here:

 
More from Bloomberg Business
Connect with us on…
X:
Facebook:
Instagram:
LinkedIn:
TikTok:

Continue Reading

Trending